Are you Dr. Botson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 81 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3890 University Lake Dr Ste 110
Anchorage, AK 99508Phone+1 907-562-2277Fax+1 907-563-3460
Summary
- Dr. John Botson, MD is a rheumatologist in Anchorage, Alaska. He is currently licensed to practice medicine in Alaska, Hawaii, and Maryland. He is affiliated with Providence Alaska Medical Center, Alaska Regional Hospital, and Mat-Su Regional Medical Center.
Education & Training
National Institutes of Health Clinical CenterFellowship, Rheumatology, 2007 - 2009
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2004 - 2007
Ohio State University College of MedicineClass of 2004
Certifications & Licensure
HI State Medical License 2021 - 2026
OH State Medical License 2000 - 2025
AK State Medical License 2007 - 2024
NH State Medical License 2004 - 2024
MD State Medical License 2007 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Quality of life and clinical gout assessments during pegloticase with and without methotrexate co-therapy: MIRROR randomized controlled trial exploratory findings.John Botson, Katie Obermeyer, Brian LaMoreaux, Lissa Padnick-Silver, Supra Verma
Rheumatology Advances in Practice. 2024-01-01 - 6 citationsA Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Rece...John K Botson, Kenneth Saag, Jeff Peterson, Katie Obermeyer, Yan Xin
ACR Open Rheumatology. 2023-08-01 - 15 citationsA Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety...John K Botson, Kenneth Saag, Jeff Peterson, Naval Parikh, Stephen Ong
Arthritis & Rheumatology. 2023-02-01
Press Mentions
Options for Refractory Gout, ILD & MoreNovember 18th, 2022- Combination Therapy Effective for Hard-to-Treat Patients with GoutNovember 14th, 2022
- Twelve-Month Data Back Pegloticase-Methotrexate Gout ComboNovember 13th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
